Paper - WANFANG MED ONLINE

You Position: Home > Paper

麻风周围神经功能损害及其防治

( views:182, downloads:20 )

Author:: No author available

Journal Title:: FOREIGN MEDICAL SCIENCES(SECTION OF DERMATOLOGY AND VENEREOLOGY)

Issue:: 5

DOI:: 10.3760/cma.j.issn.1673-4173.2005.05.001

Key Word:: 麻风;神经功能损害;糖皮质激素类

Abstract：麻风神经功能损害是麻风作为公共卫生问题的最重要原因之一.麻风型别和疗前是否有麻风神经功能损害是发生新麻风神经功能损害的最危险因素.应对所有新发现的麻风患者定期进行神经功能检测并对新发麻风神经功能损害给予糖皮质激素治疗.糖皮质激素对陈旧性麻风神经功能损害无明显疗效;预防性治疗不能明显降低新发麻风神经功能损害的发病率.

Reference

[1]Richardus JH,Croft RP,Smith WC,etc.Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh.[J].1996,67(4).
[2]Bernink EH,Voskens JE.Study on the detection of leprosy reactions and the effect of prednisone on various nerves, Indonesia.[J].1997,68(3).
[3]W H, van Brakel,J, Shute,J A, Dixon,etc.Evaluation of sensibility in leprosy--comparison of various clinical methods.[J].1994,65.
[4]R P, Croft,P G, Nicholls,J H, Richardus,etc.Incidence rates of acute nerve function impairment in leprosy: a prospective cohort analysis after 24 months (The Bangladesh Acute Nerve Damage Study).[J].2000,71.
[5]W H, van Brakel,I B, Khawas,K S, Gurung,etc.Intra- and inter-tester reliability of sensibility testing in leprosy.[J].1996,64.
[6]J M, Watson.Disability control in a leprosy control programme.[J].1989,60.
[7]Richardus JH,Withington SG,Anderson AM,etc.Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials.[J].2003,74(4).
[8]H.K. KAR,R.S. MISRA,PANKAJ SHARMA.Reactional states and neuritis in multibacillary leprosy patients following MDT with/without immunotherapy with Mycobacterium w anti- leprosy vaccine[J].2000,71(2).
[9]P W, Roche,J, Le Master,C R, Butlin.Risk factors for type 1 reactions in leprosy.[J].1997,65(4).
[10]Kumar V,Sengupta U.Ultrastructural study of Schwann cells and endothelial cells in the pathogenesis of leprous neuropathy.[J].2003,71(4).
[11]A, Meima,P R, Saunderson,S, Gebre,etc.Factors associated with impairments in new leprosy patients: the AMFES cohort.[J].1999,70.
[12]J, Jiang,J M, Watson,G C, Zhang,etc.A field trial of detection and treatment of nerve function impairment in leprosy--report from national POD pilot project.[J].1998,69.
[13]Van Brakel WH,Anderson AM,Smith WC,etc.Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3).[J].2003,74(4).
[14]R P, Croft,P G, Nicholls,J H, Richardus,etc.The treatment of acute nerve function impairment in leprosy: results from a prospective cohort study in Bangladesh.[J].2000,71.
[15]Brandsma JW,Van Brakel WH.WHO disability grading: operational definitions.[J].2003,74(4).
[16]W Cairns S Smith,Alison M Anderson,Stephen G Withington,etc.Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1)[J].2004,328(7454).
[17]P, Rose,M F, Waters.Reversal reactions in leprosy and their management.[J].1991,62.
[18]Nicholls PG,Croft RP,Smith WC,etc.Delay in presentation, an indicator for nerve function status at registration and for treatment outcome--the experience of the Bangladesh Acute Nerve Damage Study cohort.[J].2003,74(4).
[19]Wagner MB,Ferreira J,Mengue SS,etc.Estimating hidden prevalence in Hansen's disease through diagnosis delay and grade of disability at time of diagnosis.[J].2000,68(4).
[20]W H, Van Brakel,I B, Khawas,S B, Lucas.Reactions in leprosy: an epidemiological study of 386 patients in west Nepal.[J].1994,65.
[21]Smith WC,Croft RP,Richardus JH.Field treatment of acute nerve function impairment in leprosy using a standardized corticosteroid regimen--first year's experience with 100 patients.[J].1997,68(4).
[22]Schreuder PA.The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 (correction of 1978-1995). III. Neural and other impairments (see comments) (published erratum ap[J].1998,66(2).
[23]Richardus JH,Smith WC,Anderson AM,etc.The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2).[J].2003,74(4).
[24]A M, Anderson,R P, Croft.Reliability of Semmes Weinstein monofilament and ballpoint sensory testing, and voluntary muscle testing in Bangladesh.[J].1999,70.